GIOS Biostructures offers integrated services including structure determination, fragment-based screening, de novo protein design, and protein engineering. The company uses an automated X-ray crystallography platform and synchrotron access to accelerate drug discovery research. Services span from gene-to-protein expression and purification to protein structure determination and AI-based protein design via their GIOS MESO platform™.
Evgenii Osipov - Co-Founder
Giel Stalmans - Co-Founder